1. Home
  2. NABL vs GLPG Comparison

NABL vs GLPG Comparison

Compare NABL & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NABL
  • GLPG
  • Stock Information
  • Founded
  • NABL 2000
  • GLPG 1999
  • Country
  • NABL United States
  • GLPG Belgium
  • Employees
  • NABL N/A
  • GLPG N/A
  • Industry
  • NABL Computer Software: Prepackaged Software
  • GLPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • NABL Technology
  • GLPG Health Care
  • Exchange
  • NABL Nasdaq
  • GLPG Nasdaq
  • Market Cap
  • NABL 1.9B
  • GLPG 1.8B
  • IPO Year
  • NABL N/A
  • GLPG 2005
  • Fundamental
  • Price
  • NABL $7.10
  • GLPG $25.12
  • Analyst Decision
  • NABL Buy
  • GLPG Sell
  • Analyst Count
  • NABL 4
  • GLPG 5
  • Target Price
  • NABL $9.38
  • GLPG $26.75
  • AVG Volume (30 Days)
  • NABL 1.4M
  • GLPG 159.8K
  • Earning Date
  • NABL 03-03-2025
  • GLPG 04-23-2025
  • Dividend Yield
  • NABL N/A
  • GLPG N/A
  • EPS Growth
  • NABL 24.64
  • GLPG N/A
  • EPS
  • NABL 0.16
  • GLPG 1.16
  • Revenue
  • NABL $466,147,000.00
  • GLPG $285,380,474.00
  • Revenue This Year
  • NABL $8.45
  • GLPG $0.08
  • Revenue Next Year
  • NABL $9.68
  • GLPG $0.23
  • P/E Ratio
  • NABL $45.38
  • GLPG $21.87
  • Revenue Growth
  • NABL 10.49
  • GLPG 14.99
  • 52 Week Low
  • NABL $6.75
  • GLPG $22.36
  • 52 Week High
  • NABL $15.49
  • GLPG $32.57
  • Technical
  • Relative Strength Index (RSI)
  • NABL 32.95
  • GLPG 42.30
  • Support Level
  • NABL $7.09
  • GLPG $25.07
  • Resistance Level
  • NABL $7.38
  • GLPG $25.72
  • Average True Range (ATR)
  • NABL 0.27
  • GLPG 0.51
  • MACD
  • NABL 0.03
  • GLPG -0.13
  • Stochastic Oscillator
  • NABL 10.66
  • GLPG 24.11

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Share on Social Networks: